California Western Law Review
Volume 55

Number 2

Article 9

7-29-2019

Marketing Medicine to Millennials: Preparing Institutions and
Regulations for Direct-to-Consumer Healthcare
Mollie Levy

Follow this and additional works at: https://scholarlycommons.law.cwsl.edu/cwlr

Recommended Citation
Levy, Mollie (2019) "Marketing Medicine to Millennials: Preparing Institutions and Regulations for Directto-Consumer Healthcare," California Western Law Review: Vol. 55 : No. 2 , Article 9.
Available at: https://scholarlycommons.law.cwsl.edu/cwlr/vol55/iss2/9

This Comment is brought to you for free and open access by CWSL Scholarly Commons. It has been accepted for
inclusion in California Western Law Review by an authorized editor of CWSL Scholarly Commons. For more
information, please contact alm@cwsl.edu.

Levy: Marketing Medicine to Millennials: Preparing Institutions and Reg
Mollie Levy camera ready FINAL (Do Not Delete)

7/10/2019 9:10 AM

MARKETING MEDICINE TO MILLENNIALS:
PREPARING INSTITUTIONS AND REGULATIONS FOR
DIRECT-TO-CONSUMER HEALTHCARE
TABLE OF CONTENTS
INTRODUCTION ................................................................................. 522
I. THE BUSINESS OF HEALTHCARE.................................................... 524
A. The Current Healthcare Model ......................................... 525
B. Technology and Healthcare .............................................. 528
C. The Shift in Healthcare Delivery ...................................... 530
II. DIRECT-TO-CONSUMER MEDICINE .............................................. 533
A. Direct-to-Consumer Advertising in Healthcare ................ 534
B. Direct-to-Consumer Health Products ............................... 535
1. Medical Devices .......................................................... 536
2. The mHealth Boom ..................................................... 538
3. Pharmaceuticals ......................................................... 539
C. Current Regulations .......................................................... 540
III. CONCEPTUALIZING POSSIBLE SOLUTIONS TO PROTECT THE
PATIENT-CONSUMER ........................................................................ 542
A. Retroactive Responses ....................................................... 543
1. Medical Education ...................................................... 543
2. Service Costs ............................................................... 545
3. Pharmaceutical Drug Costs........................................ 546
B. Proactive Reform .............................................................. 548
1. The FTC and HIPAA................................................... 548
2. mHealth Regulation .................................................... 549
3. Monopoly Oversight.................................................... 550
CONCLUSION .................................................................................... 550
Change is coming to how healthcare is delivered in the United
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that they be efficient, and cost-effective. Unfortunately, the traditional
healthcare delivery model is simply incompatible with these needs.
This is due in part to the shortfalls of current regulatory structures, and
the complexities of the healthcare marketplace generally. Huge tech
companies have taken note of new demands resulting from the
dissonance between our healthcare system, the market for its current
service structure, and the deleterious effects of federal regulations.
Targeting to the needs of the emerging, tech-dependent generations,
and exploiting regulators’ and healthcare institutions’ failure to adapt,
big tech is on a path to consolidating an essentially unregulated method
of healthcare delivery – direct-to-consumer goods and services. This
article examines the inevitable shifts in healthcare markets that are to
come, and touches on areas that regulators have – as yet – failed to take
proactive measures. By examining current and past shortfalls in
healthcare regulation, this article illuminates imminent issues that need
to be addressed by considered legislation. The healthcare industry has
a lot to lose if giant tech companies consolidate healthcare delivery
markets before some action is taken – the time for such action is now.
INTRODUCTION
It’s Sunday morning and you wake with a pain in the back of your
throat. While putting on a pot of tea, you enter your symptoms
including fever and elevated white blood cell count, per your
smartwatch, into an app. Before the tea kettle steams, you are
discussing your sore throat with a provider, and one hour later a
treatment pack arrives at your doorstep. Can you imagine a world like
this, where you could receive healthcare on demand, at your
convenience, without leaving your own home? Amazon and Google
can, in fact, six of the largest companies in the world are betting billions
that you can. 1
Healthcare is likely to become the next industry revolutionized by
the Millennial consumer, just as other traditional purchase models have
adapted to meet the growing change in consumer expectations. Big
tech’s recent involvement in the healthcare industry suggests such a
1. In 2018 alone, Amazon, Apple, Berkshire-Hathaway, JPMorgan Chase, and
Google invested billions in major health initiatives. Robert Pearl, Why Did Google
Hire Geisinger CEO Dr. David Feinberg, FORBES (Nov. 10, 2018, 8:42 AM),
https://www.forbes.com/sites/robertpearl/2018/11/10/google/#2558a2 d242c0.

https://scholarlycommons.law.cwsl.edu/cwlr/vol55/iss2/9

2

Levy: Marketing Medicine to Millennials: Preparing Institutions and Reg
Mollie Levy camera ready FINAL (Do Not Delete)

2019]

MARKETING MEDICINE TO MILLENNIALS

7/10/2019 9:10 AM

523

looming disruption of the current healthcare delivery model; however,
the traditional healthcare industry is inapposite to a developing “directto-consumer healthcare” approach where companies are born online
and sell directly to their customers, effectively eliminating the need for
a storefront. 2 In the case of healthcare, a direct-to-consumer model
eliminates much of existing traditional healthcare delivery in hospitals
and face-to-face visits.
Considered the first digitally native generation, Millennials 3 have
unique expectations of technology that differ from any preceding
generation. 4 Unlike Baby Boomers 5 and GenXers, 6 Millennials expect
technology to be readily available and efficiently meet most of their
needs. 7 Consequently, this dependence on technology has adjusted the
Millennial perception of services and Millennials display entirely new
patterns of social and purchasing behavior. 8 Most industries have

2. Adele Chapin, What is the Direct-to-Consumer Sales Model and Why Should
you Care, RACKED (Aug. 11, 2016, 10:02 AM), https://www.racked.com/2016/8/11/
12412470/direct-to-consumer-sales-explainer (explaining the recent development of
the direct-to-consumer business model).
3. Based on a July 1, 2017 census, there are 30.6 million millennials in the
United States, accounting for over 23% of the population. So How Many Millennials
Are There in the US, MARKETING CHARTS (Apr. 30, 2018), https://www.marketing
charts.com/featured-30401 [hereinafter How Many Millennials].
4. Micah Solomon, For Small Businesses Week: All About Millennial
Consumers and Millennial-Friendly Customer Experiences, FORBES (May 3, 2018,
9:26 PM), https://www.forbes.com/sites/micahsolomon/2018/05/03/for-small-busin
ess-week-all-about-millennial-consumers-and-millennial-friendly-customer-experien
ces/#648644292f91.
5. Baby Boomers are those born between the mid-1940s to the 1960s. Anna
Johnston, Gen When?, THE SUN (May 25, 2018, 3:00 PM), https://www.thesun.
co.uk/fabulous/5505402/millennials-baby-boomers-generation-groups-z-y-x-explain
ed/.
6. GenXers are those born between the mid-1960s and the early 1980s. Id. This
generation is savvy, skeptical, self-reliant, and known for its work ethic. Paul Taylor
& George Gao, Generation X: America’s Neglected ‘Middle Child’, PEW RES.
CENTER (June 5, 2014), http://www.pewresearch.org/fact-tank/2014/06/05/generatio
n-x-americas-neglected-middle-child.
7. Solomon, supra note 4.
8. Maxime Rieman, Insurance Companies Need to Adjust Product and
Approach to Address Millennials, FORBES (Jan. 5, 2018, 8:30 AM), https://www.for
bes.com/sites/forbesbusinessdevelopmentcouncil/2018/01/05/insurance-companiesneed-to-adjust-product-and-approach-to-address-millennials/#3fdc01a87a4d.
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embraced these shifts in an effort to capture the disposable income of
the population’s largest generation.
Traditional service industries have redefined delivery methods and
identified marketing strategies to provide constant, continuous, and
convenient access to their products, knowing they will profit
significantly from Millennials. But the traditional healthcare industry
has failed to keep pace, and Millennials are, perhaps consequently, the
least likely to seek medical treatment. Possibly due to high cost and
general inconvenience, Millennials are driven to a familiar marketplace
that meets their healthcare needs on demand: online platforms and
direct-to-consumer health products. Contrary to the traditional model,
these alternatives provide answers in real time, for next-to-no cost.
This article examines legal shortfalls in the United States as they
relate to this shift in healthcare delivery, driven by Millennials, to
direct-to-consumer medicine. Part I of this article will review the
business of healthcare, focusing on the current delivery model and its
recent incorporation of technology. Part II will examine forms of
direct-to-consumer medicine, focusing on direct-to-consumer
advertising and the direct-to-consumer health products available today.
Part III will discuss possible strategies to protect the patient-consumer
during this shift in healthcare delivery to direct-to-consumer medicine,
assessing first a retroactive response and finally proactive reform. This
article will conclude by highlighting the imminent need for institutions
and regulators to address these changes before the face of healthcare is
changed forever – to the detriment of the healthcare industry.
I. THE BUSINESS OF HEALTHCARE
Healthcare is one of the largest industries in the United States,
employing approximately 13,000,000 American workers, 9 and
accounting for nearly 18% of the GDP. 10 Interestingly, healthcare is a

9. Total Health Care Employment, HENRY J. KAISER FAM. FOUND.,
https://www.kff.org/other/state-indicator/total-health-care-employment (last visited
May 1, 2019).
10. D. Yoni Blumberg, Here’s the Reason Health Care Costs So Much More in
the US, CNBC (Mar. 22, 2018, 11:37 AM), https://www.cnbc.com/2018/03/22/thereal-reason-medical-care-costs-so-much-more-in-the-us.html (citing Irene Papanicolas, Liana Woskie & Ashish Jha, Health Care Spending in the United States and
Other High-Income Countries, 39 JAMA 1024 (2018)).

https://scholarlycommons.law.cwsl.edu/cwlr/vol55/iss2/9

4

Levy: Marketing Medicine to Millennials: Preparing Institutions and Reg
Mollie Levy camera ready FINAL (Do Not Delete)

2019]

MARKETING MEDICINE TO MILLENNIALS

7/10/2019 9:10 AM

525

social need, yet simultaneously an extremely lucrative business. Like
other industries, healthcare is a service. What makes healthcare unlike
most industries, however, is that it provides a service that is not only
essential to society, but also operates based on individually specified
needs. For example, a patient does know when they will be diagnosed
with cancer or hit by a car and require care. Consequently, in an effort
to ensure Americans have the ability to obtain healthcare when it is
required, legislatures place extensive regulations on the industry at the
state and federal level. 11 Unfortunately, some of these regulations
inhibit the healthcare industry’s ability to incorporate changing societal
and consumer expectations driven by the emergence of the Millennial
consumer cohort.
A. The Current Healthcare Model
The United States notoriously over-spends on healthcare, with
costs nearly double those of comparable industrialized countries.12
Despite having the most expensive medical care in the world, the
United States’ healthcare system is the worst-performing of eleven
developed countries – including Canada, France, Germany, and the
U.K. – in terms of access, efficiency, and equity. 13
Healthcare delivery in the U.S. is an anomaly among developed
countries in that it operates mostly through private hospitals and
physician-negotiated fee structures. 14
Pricing is thus largely
unconstrained, resulting in rising costs of medication, medical services,
and hospital administration. 15 Treatment compensation levels are also
11. Needless to say, the number of healthcare regulations that effect the market
vast; thus, this comment will not address most of the complexities of healthcare
regulation.
12. In 2016, the United States spent 17.8% of its GDP on health care,
meanwhile, the average spending of ten other high-income countries (Canada,
Germany, Australia, the U.K,. Japan, Sweden, France, the Netherlands, Switzerland,
and Denmark) was only 11.5%. Blumberg, supra note 10.
13. Olga Khazan, U.S. Healthcare: Most Expensive and Worst Performing, THE
ATLANTIC (June 16, 2014), https://www.theatlantic.com/health/archive/2014/06/ushealthcare-most-expensive-and-worst-performing/372828.
14. Arthur Daemmrich, U.S. Healthcare Reform and the Pharmaceutical
Industry 4 (Working Paper 12-015 Sept. 14, 2011), https://www.hbs.edu/faculty/Publ
ication%20Files/12-015.pdf.
15. Blumberg, supra note 10.
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largely driven by Medicare reimbursement rates, which are set by the
government, 16 and consequently hospital systems often push providers
to meet standardized performance measures to comply with
requirements outlined by the federal government. 17 While this
procedure was implemented in an effort to improve quality, instead it
placed unnecessary and distracting requirements on the patient visit –
frustrating both the patient and the provider. For example, 2019 marks
“year three” of Medicare MIPS reimbursement model. 18 Under this
program, providers receive an allocated deduction of 7% in Medicare
reimbursement costs for failing to satisfy quality reporting measures. 19
While this program in theory promotes quality of care, because these
guidelines are generalized, a Medicare patient being seen for a specific
issue may be required to answer seemingly irrelevant questions about
their general health in an effort for the provider to meet the MIPS
measure. 20 In essence, these Medicare reimbursement guidelines are
complex, confusing, and often force providers to focus on ways to meet
16. Tamera Jackson, Medicare Reimbursement, MEDICARE.COM (July 6, 2018),
https://medicare.com/administration/how-do-i-get-reimbursed-by-medicare.
17. Congress has served as a catalyst for this trend in its efforts to convert
Medicare reimbursement rates to a merit-based system. Alas, “CMS is required by
law to implement quality payment incentive program[s],” including the Merit-based
Incentive Payment System (MIPS) to meet those requests, replacing previous
programs like PQRS. Under MIPS, eligible-clinicians (determined by clinician type,
volume of charges under the Medicare Physician Fee Schedule, and the number of
Medicare Part B patients) are rewarded based on value and patient outcomes. Each
clinician’s performance measure is determined on scores in quality, improvement
activities, promoting interoperability, and cost. Each category is based on specific
measures created by CMS. Performance in these categories are converted into a score,
which determines each clinician’s payment adjustment for their Medicare patients.
Thus, clinicians are required to meet these measures to “earn” the greatest
reimbursement. MIPS Overview, DEP’T OF HEALTH & HUMAN SERVICES, https://qpp.
cms.gov/mips/overview (last visited May 1, 2019).
18. Susan Moschella, 2019 MIPS Requirements, MEDISOLV: BLOG (Nov. 16,
2018), https://blog.medisolv.com/2019-mips-requirements.
19. Id. “Each category of MIPS has a different set of requirements that you
must follow in order to fully participate and have your best chance at earning incentive
money. There are four categories that make up the MIPS program: quality, promoting
interoperability (formerly advancing care information), improvement activity, and
cost. Each of these categories carries a different weight. Your score in each category
will be totaled into one final MIPS score.” Id.
20. 2019 MIPS Rules, MD INTERACTIVE, https://mdinteractive.com/2019-mipsrules (last visited May 1, 2019).
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a reimbursement measure rather than a patient’s chief complaint.
Moreover, given its profitability, current and conventional healthcare
policy focuses on “cost versus quality.” 21
Americans spend 60% more on insurance than citizens of any other
developed country in the world and typically receive health insurance
through their employer, the government, or a private payer system. 22
Those who are unable to afford private coverage, do not receive benefits
from their employer, and are not eligible for Medicare, 23 may be
eligible for Medicaid; 24 but many have no coverage at all. 25 This
system functions as an incomplete patchwork of coverage, leaving
many Americans unable to afford insurance premium costs. 26
Consequently, the healthcare industry covers the costs for those who
choose, or are financially obliged not to have health insurance. 27
Furthermore, healthcare costs are greatly influenced by the United
States pharmaceutical market, 28 which totals over $1 trillion a year. 29
The United States has a unique approach to pharmaceuticals as its drug
regulations do not extend beyond safety and efficacy. Therefore, once
approved under the safety standards set forth by the Food and Drug
21. Nicolas P. Terry, Will the Internet of Things Transform Healthcare?, 2
VAND. J. ENT. & TECH. L. 327, 329 (2016).
22. Daemmrich, supra note 14, at 2.
23. See 42 U.S.C. § 1395c (2019).
24. See 42 U.S.C. § 1396a(a)(10) (2018).
25. Guixiang Zhao et al., Trends of Lack of Health Insurance Among US Adults
Aged 18-64 Years: Findings from the Behavioral Risk Factor Surveillance System,
1993-2014, 146 PUB. HEALTH 108, 109 (2017).
26. Notably, 60% of bankruptcies in 2007 stemmed from medical debts.
Daemmrich, supra note 14, at 2 (citing David Himmelstein et al., Medical Bankruptcy
in the United States, 2007: Results of a National Survey, 122 AM. J. MED. 74 (2009)).
27. Maureen Groppe, Who Pays When Someone Without Insurance Shows Up
in the ER?, USA TODAY (July 13, 2017, 1:14 AM), https://www.usatoday.com/story
/news/politics/2017/07/03/who-pays-when-someone-without-insurance-shows-uper/445756001.
28. The United States holds over 45% of the global pharmaceutical market. U.S.
Pharmaceutical Industry – Statistics & Facts, STATISTA, https://www.statista.com/to
pics/1719/pharmaceutical-industry (last visited May 1, 2019).
29. In 2015, the economic output from the pharmaceutical industry included
$558 billion in revenue for biopharmaceutical businesses and $659 billion from
suppliers and worker spending. Biopharmaceutical Spotlight: The Biopharmaceutical
Industry in the United States, SELECT USA, https://www.selectusa.gov/pharmaceu
tical-and-biotech-industries-united-states (last visited May 1, 2019).
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Administration (FDA), the government does not regulate or negotiate
prescription drug prices. 30 Many other countries task government
agencies with determining prescription pricing. 31 Instead, the United
States allows drug makers to set their own prices for a given
prescription. 32 As a result, each of the thousands of health insurance
plans, including Medicare, negotiates its own prices with drug makers
separately. 33
Unfortunately for the American consumer, the fragmented
dispersal of health insurance plans has diminished insurers’ bargaining
power to demand lower prescription costs for their policy holders. 34
Consequently, the cost of a given medication differs drastically in the
United States compared to the cost of the same medication in any other
country in the world. 35
B. Technology and Healthcare
In light of growing demand, the healthcare industry has shifted its
willingness to incorporate technology into the traditional delivery
model. Industry professionals believe incorporating technology will
improve quality of care and accessibility of healthcare services.
Beyond technological advances in care specifically, hospital systems
have been encouraged to embrace technology since the early 2000s. At
that time, lawmakers hoped to incentivize hospital systems to transition
from paper to electronic charting by including the Privacy Rule in an
effort to improve documentation and patient care. 36
30. Sarah Kliff, The True Story of America’s Sky-High Prescription Drug
Prices, VOX (May 10, 2018, 9:19 AM), https://www.vox.com/science-and-health/
2016/11/30/12945756/prescription-drug-prices-explained.
31. Id.
32. Id.
33. Nearly every drug approved by the FDA is covered by Medicare because
Federal law expressly prohibits negotiating drug prices or making decisions about
which drugs it covers. Id.
34. Id.
35. For example, in 2015, the prescription medication “Humira” (used to treat
arthritis and psoriasis) cost approximately $1,362 in the United Kingdom, $822 in
Switzerland, and $2,669 in the United States. Id.
36. Recognizing a need to “maintain strict privacy protection for health
information,” Congress authorized the Privacy Rule which “creates national standards
to keep individuals’ medical records and other personal health information
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More recently, technology is making its way into the physicianpatient encounter. First introduced by NASA in the 1960s to provide
treatment to astronauts, 37 today telemedicine – utilizing audio and video
equipment to establish “two-way, real time interactive communication
between the patient, and the physician or practitioner at a distant site”38
– provides a cost-effective alternative to the traditional face-to-face
healthcare delivery model by servicing remote or underserved
communities. 39 While telemedicine is not new, federal and state
legislatures have failed to recognize its benefits on expanding access,
decreasing cost, and improving quality of care until recently. 40 For
example, not until 2018 did Congress pass a law to authorize
reimbursement for care provided via telemedicine to rural
populations. 41
However, nearly a decade earlier Congress began allowing online
pharmacies to exist and operate freely. 42 Unlike the tight regulations
restricting traditional healthcare delivery, online pharmacies are merely
required to satisfy state regulations. 43 Given the majority of online
pharmacies are based outside of the United States, these companies
have circumvented regulation. 44 Consequently, the illegal prescription

confidential” by restricting health care providers from releasing patient medical
records and guaranteeing patient access to their medical records. 45 C.F.R. §§ 160,
164.524(b)(2) (2013).
37. Vera Gruessner, The History of Remote Monitoring, Telemedicine
Technology, MHEALTH INTELLIGENCE (Nov. 9, 2015), https://mhealthintelligence.
com/news/the-history-of-remote-monitoring-telemedicine-technology.
38. Telemedicine, MEDICAID.GOV, https://www.medicaid.gov/medicaid/bene
fits/telemed/index.html (last visited May 1, 2019).
39. Ioana Ciopraga, The FDA Guidance Document of Medical Mobile Apps and
its Impact on Innovation: Bringing the Promise of a New Way to Look at Medicine
Closer, or Pushing it Further, 6 J.L. TECH. & INTERNET 43, 45-46 (2015).
40. Telemedicine Benefits, AM. TELEMEDICINE ASS’N., http://www.american
telemed.org/main/about/about-telemedicine/telemedicine-benefits (last visited May
1, 2019).
41. 38 U.S.C. § 1730C (2018); see also id.
42. 21 U.S.C. § 831 (2009).
43. Ross D. Silverman, Regulating Medical Practice in the Cyber Age: Issues
and Challenges for State Medical Boards, 26 AM. J. L. & MED. 255, 267 (2000).
44. A random sample of 10,000 online pharmacies by the FDA found that 97%
of them were either illegal or out of compliance with regulations. Illegal Online
Pharmacies: How Endemic Are They?, PHARMACEUTICAL TECH. (July 20, 2018),
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drug market has blossomed over the last decade, and there are
approximately 40,000 illegal online pharmacies today. 45
The online pharmaceutical market also incentivizes patients to
avoid the traditional healthcare model, as patients seek faster treatment
by skipping the face-to-face provider visit and locating a desired
medication online. 46 In effect, online prescribing represents another
way in which the internet offers “unparalleled opportunities for
individuals to get exactly what they want.” 47 It is no surprise that one
in four American consumers purchases their prescription medications
online. 48 Thus, the healthcare industry has made attempts to incorporate
technology into its traditional delivery model, but is limited by the
limited pace of legislation and political priorities. The difference in
Congress’ treatment of telemedicine and online pharmacies shows that
inconsistencies in regulation that leave the markets for healthcare
delivery open to abuse lead to direct, negative impacts on consumers.
C. The Shift in Healthcare Delivery
Without question—tech companies are betting on healthcare. 49
Within the last five years, the top ten tech companies in the United
States have spent over $4.5 billion to finance healthcare projects.50
Since the introduction of eCommerce, companies like Amazon have run
out competitors in numerous markets by offering direct-to-consumer
products at minimal cost, time, or risk to the consumer. 51 Healthcare
https://www.pharmaceutical-technology.com/comment/illegal-online-pharmaciesendemic [hereinafter Illegal Online Pharmacies].
45. Id.
46. Silverman, supra note 43, at 266.
47. Id.
48. Illegal Online Pharmacies, supra note 44.
49. See Where Big Tech is Placing Bets in Healthcare, CB INSIGHTS (Sept. 13,
2018), https://www.cbinsights.com/research/top-tech-companies-healthcare-investm
ents-acquisitions [hereinafter Tech Bets]; see generally Pearl, supra note 1.
50. Id.
51. Experts believe Amazon is currently threatening healthcare, electronic
retailers, consumable manufacturers, department stores, high-end department stores,
food delivery, bookstores, grocery stores, package delivery and logistics. Kate
Taylor, Mary Hanbury, & Dennis Green, Amazon’s Growth Could Threaten These 10
Industries, BUS. INSIDER (June 28, 2018, 12:11 PM), https://www.businessinsider.
com/amazon-is-killing-these-7-companies-2017-7#pharmacy-9.
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has become Amazon’s most recent target, and in a recent acquisition
the company purchased an eCommerce prescription medication
platform called PillPack for close to $1 billion. 52
This buy-in is indicative of a pattern of market shifts we have seen
in other sectors. In the 1980s, mega retailers like K-Mart, Sears, and
Target were the typical outlet for average consumers to shop for
household items; today, all but one has filed for bankruptcy. 53 This is
largely due to eCommerce’s ability to consolidate markets because of
its superior convenience and cost-effectiveness. Amazon’s investment
in pharmaceutical eCommerce is a strong sign that swaths of the
healthcare industry may fall in the same way. Thus, a change in
healthcare delivery is undoubtedly inevitable. As such, without
legislative reform allowing direct-to-consumer products in the industry,
the traditional healthcare delivery model may meet a similar fate as that
of Blockbuster 54 and Borders Books. 55
With the recent generation shift, Millennials have become the
largest segment of the American consumer market. 56 However,
52. Ingrid Lunden, Amazon Buys PillPack, an Online Pharmacy, for Just Under
$1B, TECH CRUNCH (June 2018), https://techcrunch.com/2018/06/28/amazon-buyspillpack-an-online-pharmacy-that-was-rumored-to-be-talking-to-walmart.
53. See Chris Isidore, Sears’ Extraordinary History: A Timeline, CNN (Oct. 15,
2018), https://www.cnn.com/interactive/2018/10/business/sears-timeline/index.html;
Jeanette L. Nolen, Target Corporation: American Corporation, ENCYCLOPEDIA
BRITANNICA (Mar. 14, 2019), https://www.britannica.com/topic/Target-Corporation;
A Timeline of the Kmart Corporation, N.Y. TIMES (Jan. 22, 2002), https://www.nyt
imes.com/2002/01/22/business/a-timeline-of-the-kmart-corporation.html.
54. Blockbuster went bankrupt in 2000 after refusing to accept a partnership
offer from Netflix, an online media streaming company which is now the world’s most
highly valued media and entertainment company. Greg Satell, A Look at Why
Blockbuster Really Failed and Why it Didn’t Have to, FORBES (Sept. 5, 2014),
https://www.forbes.com/sites/gregsatell/2014/09/05/a-look-back-at-why-blockbuster
-really-failed-and-why-it-didnt-have-to/#21934d011d64.
55. Borders Books went bankrupt in 2011 after outsourcing its online book sales
to Amazon instead of developing a competitive e-reader device or offering sales
online. Josh Sanburn, 5 Reasons Boarders Went Out of Business (and What Will Take
its Place), T IME (July 19, 2011), http://business.time.com/2011/07/19/5-reasonsborders-went-out-of-business-and-what-will-take-its-place. Amazon is now the
world’s largest eCommerce supplier, valued at $1 trillion. Joel Anderson, How Much
is Amazon Worth?, GO BANKING RATES (July 26, 2018), https://www.gobanking
rates.com/making-money/business/how-much-is-amazon-worth.
56. According to a census taken on July 1, 2017, Millennials account for over
23% of the United States population. How Many Millennials, supra note 3.
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Millennials are the least likely to utilize the traditional healthcare
delivery model. Survey data indicates that many Millennials do not see
a doctor regularly. 57 Millennials seem to share the opinion that the
time-honored model of regular office-based primary care is fading, and
models that offer greater convenience, fast service, connectivity, and
price transparency are preferable. 58
Millennials serve a pivotal role in the success of the healthcare
industry. Without Millennials buying in to the pillared insurance
scheme while healthy, there is less money to cover the costs of older
generations. 59 That cost spreading is required to balance the high costs
of delivering healthcare to aging and illness-prone populations.60
Furthermore, without Millennials utilizing preventative medicinal
strategies, their risk of disease increases; it is uncertain whether the
industry will be able to support them when they do eventually require
focused care. 61 Simply put, the traditional model no longer fits the
desires of the average consumer, and the projected needs of the
healthcare market.
Given the huge financial incentive for online retailers to continue
consolidating an unfettered direct-to-consumer market, and the
57. A 2015 survey indicated that 9 out of 10 millennials do not see a doctor
regularly, and 51% of millennials see a doctor less than once a year. Amy Juaristi,
New Study: Why Americans are Dropping Out of Healthcare, ZOCDOC (June 23,
2015), https://www.zocdoc.com/about/news/new-study-why-americans-are-dropping
-out-of-healthcare.
58. One millennial compared the convenience of urgent care to that of “speed
dating” where the “services are rendered in a quick manner.” Sandra G. Boodman,
For Millennials, a Regular Visit to the Doctor’s Office is not a Primary Concern,
WASH. POST (Oct. 6, 2018), https://www.washingtonpost.com/national/health-scien
ce/for-millennials-a-regular-visit-to-the-doctors-office-is-not-a-primary-concern/201
8/10/05/6b17c71a-aef3-11e8-9a6a-565d92a3585d_story.html?utm_term=.fbffa34fab
71.
59. Notably, before the ACA, young adults had the highest uninsured rate of
any age group. Carmen Heredia Rodriguez, This is Why Millennials are Struggling to
Get Health Insurance, TIME (Dec. 6, 2017), http://time.com/5052313/health-insur
ance-obamacare-challenges.
60. COMM. ON THE CONSEQUENCES OF UNINSURANCE, INST. OF MED., HIDDEN
COSTS, VALUES LOST: UNINSURANCE IN AMERICA 38, 56 (US) (2003). Multigenerational cost spreading also aids in absorbing the cost of health care services
received by uninsured individuals which otherwise is covered by practitioners,
institutions, and the federal government. Id. at 60–61.
61. Boodman, supra note 58.
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generational shift towards demand for such a model, the writing is on
the wall for traditional modes of healthcare delivery. While advertising
and marketing trends within other industries have adjusted in an effort
to capitalize on comparable shifts, the traditional healthcare model has
not. The concern being that an eCommerce or direct-to-consumer
healthcare delivery model is one which the traditional healthcare
industry will be unable to incorporate without adjustments to the
government’s current tight regulatory control. As discussed below,
emerging direct-to-consumer health products are unaddressed by
current legislation. These products have the potential to expand care,
decrease costs, and capture the Millennial market. If the traditional
healthcare delivery model fails to incorporate direct-to-consumer
alternatives, the existence of the healthcare industry may be jeopardized
as the market shifts away from the traditional delivery model.
II. DIRECT-TO-CONSUMER MEDICINE
The healthcare industry has long opposed direct-to-consumer
advertising strategies, arguing they misinform patients, cripple
providers’ abilities to provide adequate care, lead to inappropriate
prescribing, and escalate drug costs. 62 Astonishingly, nearly 800,000
pharmaceutical advertisements air on television in a given year. 63
Considering the average American watches sixteen hours of
pharmaceutical television advertisements a year, the traditional
healthcare industry’s concerns are warranted. 64
While these ads have become common place, they were highly
controversial when first introduced in the 1980s. 65 At that time,
pharmaceutical companies mimicked the model used in other industries
62. Natasha Parekh & William H. Shrank, Dangers and Opportunities of Directto-Consumer Advertising, 33 J. GEN. INTERNAL MED. 586, 586 (2018) (citing C.
Lee Ventola, Direct-to-Consumer Pharmaceutical Advertising Therapeutic or
Toxic?, 36 PHARMACY & THERAPEUTICS 669, 669-74 (2011), and Kurt C. Stange,
Time to Ban Direct-to-Consumer Prescription Drug Marketing, 5 ANNALS FAM.
MED. 101, 101-04 (2007)).
63. Joanne Kaufman, Think You’re Seeing More Drug Ads on TV? You Are, and
Here’s Why, N.Y. TIMES (Dec. 24, 2017), https://www.nytimes.com/2017/12/24
/business/media/prescription-drugs-advertising-tv.html.
64. Parekh & Shrank, supra note 62, at 586.
65. The first direct-to-consumer pharmaceutical advertisement was for the
Pneumovax vaccine in 1981. Id.
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by marketing medications directly to the American consumer. This
marketing strategy encouraged patients to request specific drug
treatment from their providers, thus abrogating providers’ discretion to
recommend appropriate medications.
The strategy was
overwhelmingly successful. 66
A. Direct-to-Consumer Advertising in Healthcare
The United States is one of only two countries in the world that
permits direct-to-consumer marketing within the healthcare industry. 67
Despite growing outrage among medical providers, the FDA has been
very slow to respond to concerns raised about direct-to-consumer
marketing schemes. In the 1960s, Congress granted the FDA
prescription drug labeling and advertising regulation authority in an
effort to ensure ads were not misleading consumers. 68 However, after
direct-to-consumer advertising exploded in the 1990s, the FDA eased
previously enforced “risk” requirements. 69 Instead, the FDA merely
required direct-to-consumer pharmaceutical advertisements to include
the “major risks” associated with each medication. 70 Consequently, the
number of direct-to-consumer pharmaceutical advertisements
skyrocketed. 71
In response to continuous and systematic misrepresentation of
pharmaceutical drugs in the market, the FDA implemented new

66. “The average television viewer in the United States . . . watches as many as
nine drug advertisements per day and about 16 hours per year, far exceeding the time
an average individual spends with his/her primary physician.” Id.
67. New Zealand is the other country that permits direct-to-consumer drug
advertising; Canada also allows ads that mention the product or the indication of a
drug, but the ad cannot include both. Ventola, supra note 62, at 669.
68. This authority included ensuring that ads presented a “fair balance” of both
drug risks and benefits, included facts that are “material” to a drug’s advertised uses,
and included a “brief summary” that notes every risk described in the drug’s labeling.
Parekh & Shrank, supra note 62, at 586.
69. Id.
70. Id.
71. Today, pharmaceutical companies spend $5 billion on drug commercials a
year. Id.
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guidelines in 2012. 72 The main effect of these guidelines is that
advertisers now simply add a laundry-list of side effects to the tail-end
of advertisements. Many researchers suggest these guidelines continue
to fail the American consumer, as the “benefit vs risk” requirement 73
remains inadequate. 74 Thus, consumers continue to be misled.
Furthermore, these warnings have become so common place they are
often overlooked by the average consumer.
Recently, the FDA has been receiving more applications for directto-consumer advertisements as medical device companies are
employing similar strategies. 75 Unfortunately, the FDA struggles to
update regulations, and direct-to-consumer advertising strategies
undermine regulatory restrictions by encouraging more medical
products to be used at home.
B. Direct-to-Consumer Health Products
The demands of Millennial consumers have forced a
reconceptualization of how goods are marketed and sold. Unlike
preceding generations, Millennials quickly adopted purchasing habits
that eliminate the need of an in-person retailer. As Millennial
consumers shifted their spending to e-Commerce, other services
developed direct-to-consumer options to capitalize on the change.
Specifically, tech companies have captured the Millennial consumer
with direct-to-consumer health products, a mode of delivery the
traditional healthcare industry has not been able to adopt.

72. U.S. FOOD & DRUG ADMIN., GUIDANCE FOR INDUSTRY DIRECT-TOCONSUMER TELEVISION ADVERTISEMENTS – FDA DTC TELEVISION AD PREDISSEMINATION REVIEW PROGRAM (Draft Guidance 2012).
73. “Benefit versus risk” is the minimum requirement a product must satisfy to
obtain FDA approval; the standard is that the product’s benefits must outweigh its
risks. Parekh & Shrank, supra note 62, at 587.
74. Id. at 586–87.
75. “As the regulating body of DTC advertising, the FDA is responsible for
ensuring that advertising ‘is truthful, balanced, and accurately communicated’
through regulation, surveillance, and education.” Id. (quoting The Impact of Directto-Consumer Advertising, U.S. FOOD & DRUG ADMIN. (2015), https://www.fda.
gov/Drugs/ResourcesForYou/Consumers/ucm143562.htm).
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1. Medical Devices
Within the last ten years, biotechnology companies have
capitalized on the trend toward direct-to-consumer advertising by
focusing on medical devices for use at home. The FDA defines medical
devices as instruments “intended for use in the diagnosis of disease or
other conditions, . . . the cure, mitigation, treatment, or prevention of
disease, or . . . to affect the structure of any function of the body of man
or other animals.” 76 Unfortunately, the FDA’s conception of a medical
device fails to encompass all products available on the market for
purchase, and fails to link the medical device to the healthcare provider.
Effectively, these direct-to-consumer medical devices can create larger
gaps in care as providers are unaware of any decisions the patient may
have made based off direct-to-consumer products. 77
The rise of wearable fitness trackers is a notable example of this
phenomenon. What started as a tool to support healthy lifestyles,
evolved into a device that not only encourages but also drives care.
When introducing the newest Apple Watch model in 2018, Apple COO
Jeff Williams announced the watch’s sensor technology promises to
“become an intelligent guardian for your health.” 78 Effectively, Apple
has promised its consumers they now have the ability to monitor their
own health by means such as tracking their heart rhythm so
abnormalities can be detected by simply wearing the watch. 79 Features
like these may allow consumers to make better decisions about their
health, but they are also indicative of big tech’s leverage on the market

76. Jamie Lynn Flaherty, Digital Diagnosis: Privacy and the Regulation of
Mobile Phone Health Applications, 40 AM. J. L. & MED. 416, 422 (2015).
77. Providers make medical recommendations based on a review of the detailed
patient record, evaluation of current symptoms, and a physical examination. Critical
data captured in a direct-to-consumer product is undoubtedly missing from the
patient’s medical record.
78. On September 12, 2018, while introducing the newest model of Apple
Watch Series 4, Apple COO Jeff Williams announced the Watch’s “health sensor.”
Sara Salinas & Eugene Kim, Apple Adds Heart Monitoring to Apple Watch, CNBC
(Sept. 12, 2018, 1:13 PM), https://www.cnbc.com/2018/09/12/apple-watch-series4.html.
79. Id.
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for novel healthcare solutions. 80 As economists note: “Apple just gave
every Android user a life-saving reason to switch to the iPhone.” 81
Similar to the health monitoring services emerging from big tech,
other novel health services are becoming widespread and influential.
Nearly a decade ago, a biochemist in Silicon Valley developed the first
at home genetic testing kit that could provide health reports based on
DNA samples collected from customers’ saliva. 82 After launching in
2009, 23andMe prospered until the FDA ordered the company cease all
sales in 2013 for providing medical information directly to its
consumers from an unregulated medical device. 83
Unlike its
competitors, who focused efforts on ancestry, 23andMe advertised its
ability to provide health information while never undergoing FDA
certification. 84 Today, despite its marketing insisting information about
genetic health risks, wellness, and carrier status, 85 23andMe is only
approved to notify consumers of the risks of developing ten medical
conditions based on their DNA. 86
At home genetic testing and wearables present new problems to the
FDA; both products effectively market themselves as medical devices,
yet are shielded from regulation by the loose language of the FDA’s
definition. Furthermore, with big tech’s continued investments in the
80. It was predicted that Apple would ship 18 million units in 2018. Mikey
Campbell, Kuo: High PreOrder Demand for Apple Watch Series 4, Low Expectations
for 5.8 Inch iPhone XS, APPLE INSIDER (Sept. 16, 2018, 8:53 PM), https://appleinsider
.com/articles/18/09/16/kuo-high-preorder-demand-for-apple-watch-series-4-low-exp
ectations-for-58-inch-iphone-xs.
81. Salinas & Kim, supra note 78.
82. In 2006, Anne Wojcicki sought to disrupt the healthcare industry and put
“sophisticated DNA analyses into the hands of . . . consumers, giving them
information about health, disease, and ancestry.” Erika C. Hayden, The Rise and Rise
Again of 23andMe, NATURE (Oct. 11, 2017), https://www.nature.com/news/the-riseand-fall-and-rise-again-of-23andme-1.22801.
83. Id.
84. See David Dobbs, The F.D.A. vs. Personal Genetic Testing, THE NEW
YORKER (Nov. 27, 2013), https://www.newyorker.com/tech/annals-of-technology/
the-f-d-a-vs-personal-genetic-testing (observing that 23andMe operated without FDA
approval).
85. Our Health + Ancestry DNA Service, 23ANDME, https://www.23andme.
com/dna-health-ancestry (last visited May 1, 2019).
86. In 2017, the FDA approved notifying consumers of the risks of developing
ten specific medical conditions based on their DNA, including Parkinson’s disease
and late-onset Alzheimer’s. Hayden, supra note 82.
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industry, it is likely additional products are already in development that
are essentially medical devices, but will reach consumers without being
regulated by the FDA.
2. The mHealth Boom
Over the last five years, the prevalence of mobile health
applications (“mHealth apps”) have exploded. From 2015 to 2017, the
number of mHealth apps available for download doubled, 87 and the
market for these apps is estimated to be $26 billion.88 The FDA
estimates that over 500 million smartphone users have downloaded at
least one mHealth app. 89 Experts anticipate this boom will continue as
the mobile app economy 90 is expected to increase in size from $1.3
trillion to $6.3 trillion by 2022. 91
Unlike other direct-to-consumer products, mHealth apps allow for
unlimited access to care without significant effort by the consumer.
However, unbeknownst to the public, these mHealth apps are widely
unregulated because even apps that are considered “medical devices”
escape regulation if they are not classified as a “high risk.” 92
Regulation of mHealth apps is especially complex because it involves
four separate governmental agencies, each focusing on distinct aspects
within the application, and fails to assess the application in its entirety. 93

87. Terry, supra note 21, at 333.
88. Michelle M. Ovansian, Healthcare Begins a Mobile Revolution, 1 GEO. L.
TECH. REV. 170, 170 (2016).
89. Id. at 173.
90. App Economy includes buying and downloading applications, making
purchases within the applications, and targeted advertising within those applications.
Gene Marks, The App Economy is About to Explode, WASH. POST (June 28, 2017),
https://www.washingtonpost.com/news/on-small-business/wp/2017/06/28/the-appeconomy-is-about-to-explode/?noredirect=on&utm_term=.c48770d0a8eb.
91. Id. Economists suspect mobile shopping could be the reason behind this
expected increase, as “the mobile commerce market now accounts for approximately
90 percent of mobile app usage[.]” Id.
92. Under current law, the FDA regulates only those apps that qualify as
“medical devices and/or pose significant risks to patients” and most mHealth apps fall
outside of that category. Flaherty, supra note 76, at 418–22.
93. Current regulators of mHealth include The Health and Human Services
Office of Civil Rights, the Federal Trade Commission, the Federal Consumer
Commission, and the Food and Drug Administration. Recently, all four government
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As an example, the healthcare data collected by mHealth apps
creates an unanticipated wrinkle for the FTC, tasked with protecting
sensitive health information that is owned by individual
telecommunication carriers. Most mobile applications regulated by the
FTC are not required to comply with HIPAA’s zone of protection, 94
thus the FTC’s regulation of data is not extensive enough to protect
patient information stored in mobile data. 95, 96 Moreover, mHealth apps
face unique cyber security concerns, as the FTC has not completely
reigned in the use of consumer data, and not all suppliers even require
privacy disclosures. 97
The complexities of this emerging health technology as it relates to
FTC regulation alone illuminate the shortfalls already present in
regulation. This is so even without considering the difficulties created
by mHealth apps for the FCC, FDA, and Health and Human Services
Office of Civil Rights, and the oncoming wave of such technologies
that the current market shift promises.
3. Pharmaceuticals
The pharmaceutical industry is moving into the direct-to-consumer
realm as well, and major online retailers are tackling the traditional
pharmaceutical market head on. 98 In June 2018, Amazon acquired a
organizations “jointly developed an interactive tool in an attempt to guide application,
or app developers through the regulatory confusion.” Terry, supra note 21, at 339.
94. HIPAA, a statutory protection of privacy in health information, contains a
“zone of protection” which requires healthcare institutions to protect the disclosure of
patient health information. Mobile apps are not within this zone because HIPAA
attaches to the individual housing the data and not the data itself. Thus, since mHealth
apps are not developed or operated by a healthcare institution as defined by the law,
they are not held to guidelines required by HIPAA. Id.
95. The FDA has divided the types of mobile apps subject to oversight into three
distinct categories: (1) those that are extensions of medical devices; (2) those that
transform a mobile platform into a medical device; and (3) those that become a
regulated medical device. Ciopraga, supra note 39, at 49.
96. Flaherty, supra note 76, at 422.
97. This article will not discuss the litany of cyber security issues associated
with mHealth apps.
98. See Angelica LaVito, Amazon has Quietly Launched an Exclusive Line of
Over-the-Counter Health Products, CNBC (Feb. 20, 2018, 3:14 PM), https://www.cn
bc.com/2018/02/20/amazon-has-quietly-launched-an-exclusive-line-of-over-the-cou
nter-health-products.html.
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supplier of customized medication packs called PillPack for just under
$1 billion according to sources close to the deal. 99 PillPack offers
delivery of all prescription medications, vitamins, and any over-thecounter medications in individual daily packs for the consumer. 100 This
service makes accessing, dividing, and taking medications from
multiple medical providers easier. 101 To facilitate this process, PillPack
developed software that accounts for multiple prescriptions taken at
once. 102 This approach to prescription delivery removes the complexity
and frustration of managing multiple medications while establishing a
radical shift in chronic care management. 103
Amazon’s willingness to pay ten figures for a service like PillPack
is indicative of its potential to reshape the traditional pharmaceutical
model. 104 However, the traditional pharmacy model would never be
able to sustain such an effective service as it stands today because
traditional pharmacies do not have the infrastructure to achieve this end.
The loose regulation of online pharmacies discussed above, coupled
with big technology companies’ economic clout, thus threaten to force
ill-equipped and overregulated traditional models to fall by the wayside.
C. Current Regulations
In the last two decades, the United States government has focused
intently on issues related to healthcare because of their effect on so
many people. In the late 1990s, Congress addressed protections for
patients in the clinical setting with the passage of the Health Insurance
99. Lunden, supra note 52.
100. How it Works, PILLPACK, https://www.pillpack.com/how-it-works (last
visited May 1, 2019).
101. Id.
102. PhamarcyOS constantly monitor’s your prescriptions, making required
changes when necessary, takes a comprehensive view of client’s medications,
synchronizes medications, and tracking any anticipated changes in medications. The
Pharmacy System that Goes Beyond the Pharmacy, PILLPACK: PHARMACYOS,
https://www.pharmacyos.com (last visited May 1, 2019).
103. Id.
104. Prior to Amazon’s announcement, the “global online pharmacy market was
worth about $29 billion,” and predicted to reach $128 billion by 2023. Jim Butschili,
Amazon’s PillPack Acquisition Could Transform Online Pharmacy Market,
LOGISTICS FOR THE LIFE SCI. (July 16, 2018), https://www.logisticsforthelifesci
ences.com/amazons-pillpack-acquisition-could-transform-online-pharmacy-market.
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Portability and Accountability Act of 1996 (HIPAA). 105 HIPAA was
intended to improve the continuity of health insurance coverage,
decrease fraud, improve access to long-term care, address privacy
concerns, and simplify the administration of health insurance. 106 More
recently, Congress passed broad legislation to address the financial
impact of healthcare on patients with the Patient Protection and
Affordable Care Act. 107 While such legislation is put in place to protect
patients, it has greatly limited the ability of traditional institutions in the
industry to enter the direct-to-consumer market.
When passing HIPAA, Congress specifically targeted Medicare
fraud in an effort to protect the patient. 108 However, when it comes to
other healthcare legislation, it appears Congress was willing to overlook
possible industry-wide abuse – including Medicare fraud and substance
abuse – by allowing online pharmacies to exist with limited
restriction. 109 Perhaps persuaded by the economic impact of the
pharmaceutical industry, recent legislation suggests public policy
supports less restrictions on the sale of specific medicinal commodities
compared to the service of providing care.

105. See generally Health Insurance Portability and Accountability Act, Pub. L.
No. 104–191, 100 Stat. 2548 (1996) [hereinafter HIPAA].
106. “HIPAA represents a large and very significant legislative reform of the
health insurance industry, and is codified primarily in Titles 18, 29, and 42 of the
United States Code.” Deborah F. Buckman, Validity, Construction, and Application
of Health Insurance Portability and Accountability Act of 1996 (HIPAA) and
Regulations Promulgated Thereunder, 194 AM. L. REP. FED. 133 (2004). See also
Clay J. Countryman, HIPAA and the Practice of Law, 52 LA. B.J. 103, 103 (2004).
107. See generally Patient Protection and Affordable Care Act, 111 Pub. L. 148,
124 Stat. 119 (2010).
108. See Buckman, supra note 106.
109. A specific example of lack of oversight is the opioid epidemic. In 2017,
Health and Human Services declared the United States opioid epidemic a public
health emergency after over 47,000 Americans died from opioid overdoses in a single
year. What is the U.S. Opioid Epidemic?, U.S. DEPT. HEALTH & HUM. SERVICES,
https://www.hhs.gov/opioids/about-the-epidemic/index.html (last visited May 1,
2019). Significantly, “[t]he Centers for Disease Control and Prevention estimates that
the total ‘economic burden’ of prescription opioid misuse alone in the United States
is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction
treatment, and criminal justice involvement.” Opioid Overdoes Crisis, NAT’L INST.
DRUG ABUSE, https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdosecrisis (last visited May 1, 2019).
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Unlike the direct-to-consumer model, there are several realities that
make the traditional model uncompetitive including complicated cost
structures, time inefficiencies, and geographic challenges. The
economics of healthcare are complicated as, unlike other industries,
healthcare delivery relies primarily on insurance reimbursement to
drive cost. Under this model, healthcare providers rely on guidelines
set out by insurance companies to navigate appropriate treatment
options, which limits innovation and consumer choice. Furthermore,
the traditional model has been around for a century, and its entrenched
structure makes acquiring healthcare services a significant time
commitment for patients.110 The current model involves patient time
spent receiving, reviewing, and reconsidering treatment plans, and
receiving proper care often takes multiple visits with multiple
providers. Finally, the traditional healthcare delivery model requires
face-to-face interactions between patients and providers. The provider
must actually see and speak to the patient in order to deliver the service.
Thus, despite telemedicine, which still requires “face-to-face” contact,
the traditional healthcare delivery model faces vast institutional barriers
to meeting modern consumer needs.
These challenges highlight the overarching problem with the
traditional model: patients must spend a lot of time and money to get
treatment. Millennials are not buying into the traditional healthcare
delivery model because it directly contradicts the qualities of service
they value—namely efficiency and access. While proponents of the
traditional model may not see that demand in the market is shifting
away for precisely this reason, direct-to-consumer advertisers and tech
companies have taken note.
III. CONCEPTUALIZING POSSIBLE SOLUTIONS TO PROTECT THE
PATIENT-CONSUMER
Despite the direct-to-consumer health market being highly
saturated and profitable, 111 the traditional healthcare industry is failing
to capitalize on it. As a result, a major patient-consumer demographic,
Millennials, has drifted from the traditional model and fully embraced
new technology that can resolve their medical concerns. Most other
110. See generally Boodman, supra note 58.
111. “In 2012, there were 828 companies in the high tech medical device
industry, generating over an estimated $60 billion[.]” Ciopraga, supra note 39, at 46.

https://scholarlycommons.law.cwsl.edu/cwlr/vol55/iss2/9

22

Levy: Marketing Medicine to Millennials: Preparing Institutions and Reg
Mollie Levy camera ready FINAL (Do Not Delete)

2019]

MARKETING MEDICINE TO MILLENNIALS

7/10/2019 9:10 AM

543

industries have incorporated a direct-to-consumer strategy to increase
profits and capitalize on this shift, but the traditional healthcare model
may be unable to adapt. 112 Unfortunately, in many ways current policy
makes changing to a direct-to-consumer model impracticable.
A. Retroactive Responses
The amount of money funneled into the healthcare industry should
convince lawmakers to get out ahead of these inevitable changes in the
market, as, in reality, major changes have already taken place. Instead,
the government’s actions have handicapped the traditional healthcare
industry’s ability to embrace these shifts. To address this problem,
legislators should reflect on these market changes, and adopt
appropriate legislation. Specifically, they should take an honest look at
the hurdles the industry currently faces in its attempts to deliver
adequate care under the traditional model—the most significant of
which is cost.
Many Americans consider the cost of healthcare to be one of the
most important public policy concerns. 113 While the ACA attempted to
address consumer costs, unfortunately it did not go far enough. This is
likely because the healthcare industry is complex, entangled with many
other institutions and markets.
1. Medical Education
The problems with healthcare costs start at the beginning, as
specialty healthcare education is highly expensive and takes a long time
to complete. Additionally, a newly minted medical school graduate is
paid very little when completing residency programs required to

112. “With millennials representing the largest living generation, having now
surpassed baby boomers in total population, new patterns of purchasing and social
behavior are emerging that seem likely to change insurers that try to hold to tried-andtrue marketing practices.” Rieman, supra note 8.
113. Exit polling following the 2018 midterm elections indicated the majority
of voters felt health care was “very important” in making their voting decisions and a
quarter indicated it was their “most important issue.” Ashley Kirzinger et. al., 2018
Midterms, KFF (Oct. 18, 2018), https://www.kff.org/health-reform/poll-finding/kffelection-tracking-poll-health-care-in-the-2018-midterms.
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specialize in a desired field. 114 Depending on the specialty, residency
can range from two to seven years. 115 During that time, the majority of
physicians are unable to pay back their federal loans, as their income
does not meet the cost of required living expenses. 116 Medical school
students and residents are told that they will eventually be compensated
for their time, and it is well known that doctors are generously
compensated once they actually complete the training process. 117
As the traditional healthcare model depends heavily on the services
provided by doctors, reducing these early costs would go far to reduce
the impact on the consumer. One possible solution would be for
medical schools to consider making adjustments to expedite the
learning process. This would in turn expedite “onboarding” of
physicians into the medical profession. There are other fields that train
medical professionals without being fundamentally economically
inefficient. For example, physician assistant programs appropriately
train people without hobbling them with decades of unavoidable
debt. 118 Training programs for healthcare professionals should
114. Based on a 2018 report, despite most residents working over 60 hours per
week, the average salary for their first-year was $55,200. See Sandra Levy, Medscape
Residents Salary & Debt Report 2018, MEDSCAPE (July 18, 2018), https://www.meds
cape.com/slideshow/2018-residents-salary-debt-report-6010044#8.
115. The residency follows an internship year. Jennifer Whitlock, Doctors,
Residents, Interns, and Attendings: What’s the Difference, VERY WELL HEALTH (Oct.
31, 2018), https://www.verywellhealth.com/types-of-doctors-residents-interns-andfellows-3157293.
116. Nearly half of all medical students graduate with medical school debt
exceeding $200,000; 23% have debt exceeding $300,000. Levy, supra note 114.
117. In 2018, the median household income in the United States was $62,175.
June 2018 Median Household Income, SEEKING ALPHA, https://seekingalpha.com/
article/4193310-june-2018-median-household-income (last visited May 1, 2019).
The average salary for a single American physician in 2018 was $299,000. The
Highest-Paid Doctors (and the Lowest), According to Medscape, ADVISORY BOARD
(Sept. 5, 2018), https://www.advisory.com/daily-briefing/2018/04/11/physician-co
mpensation [hereinafter According to Medscape].
118. Physician Assistants (“PA”) earn a Master’s Degree after two to three years
of coursework. Most schools suggest the PA curriculum is extremely similar to the
“in class” curriculum taken by medical doctors. To earn a Doctorate in Medicine a
medical student is required to complete eight-week clinical rotations in each specialty
in their final two years of medical school before choosing a residency program.
However, PA’s are eligible to begin work as soon as they meet their state
qualifications. Similar to residency, PA’s gain their specialized experience on the job.
Sophie Cresswell, What is the Difference Between a Doctor and a Physician
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reconsider their pedagogical models and examine ways to cut costs or
reduce the time it takes to complete a degree in an effort to reduce
overall healthcare costs.
2. Service Costs
Service costs are extraordinarily inflated in the United States. This
is largely a reflection of administrative overhead and healthcare
professionals’ salaries. Unlike most industries that compensate based
on promotional structure, healthcare compensates based on level of
specialty and billed services. 119 This “fee for service” model drives up
cost of pay for the average patient, but most doctors fail to accept
responsibility for the cost of healthcare in the United States. 120
Furthermore, the market for healthcare services does not reflect
consumer demand. Unlike most industries where costs are driven down
by competition, health service and pharmaceutical costs in the United
States are driven up as insurers negotiate pricing with for-profit hospital
systems and pharmaceutical companies directly. 121 These costs
eventually fall back on the patient; as a result, every aspect of the
provider visit costs more in the United States than anywhere else in the
world. 122 It is no surprise that patients – especially Millennial patients
who are the least likely to invest in healthcare – are willing to consider
other available options in an effort to circumvent this system.

Assistant?, GAPMEDICS: BLOG (Oct. 16, 2013), https://www.gapmedics.com/blog
/2013/10/16/what-is-the-difference-between-a-doctor-and-a-physicians-assistant.
119. Within the last year, physicians saw an average compensation increase
ranging from 9-16%. Based on a 2018 Medscape survey, the average salary for nonspecialty preventive care physicians (pediatricians, family medicine, and internal
medicine) is $220,000. The highest salary for a specialty physician (Plastic Surgery)
is $501,000. The lowest average salary for a specialty physician (Endocrinology) is
$212,000. According to Medscape, supra note 117; see also Jacquelyn Smith, The
Best and Worst – Paying Jobs for Doctors, FORBES (July 20, 2012, 4:45 PM),
https://www.forbes.com/sites/jacquelynsmith/2012/07/20/the-best-and-worst-paying
-jobs-for-doctors-2/#1c28b1eba2a3.
120. Robert Pearl, Healthcare’s Dangerous Fee-for-Service Addiction, FORBES
(Sept. 25, 2017, 12:55 PM), https://www.forbes.com/sites/robertpearl/2017/09/25/fee
-for-service-addiction/#1e89a742c8ad.
121. See Kliff, supra note 30.
122. Blumberg, supra note 10.
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As the market forces affecting healthcare costs cut against the
consumer, and the cost of healthcare is driving consumers to options
not yet embraced by the traditional healthcare model, decision makers
should pay attention. Specifically, hospital administrators should
consider implementing available direct-to-consumer tools that fit
within the current model – such as telemedicine, mHealth, and online
pharmacies – in an effort to decrease service costs.
3. Pharmaceutical Drug Costs
Insurance companies and Congress should reconsider their
reimbursement model and realistically reform the costs of patient care
and pharmaceuticals. While lawmakers have examined numerous
methods to successfully combat the rising cost of prescription drugs in
the United States, the most impactful solution that has been proposed
would expand the price negotiation power of Medicare. 123 Some
experts believe that allowing Medicare to negotiate drug prices with
pharmaceutical companies would save the government $15 billion a
year. 124 This would also drive down costs of drugs taken by nongovernment insurance policy holders, as insurance companies often
look to Medicare for benchmark pricing when negotiating costs.
Nevertheless, this solution has met its fair share of criticism.
Patient advocacy groups fear that providing the government extended
oversight into the pharmaceutical industry will decrease patient access
to new drugs and disincentivize innovation. 125
Furthermore,
pharmaceutical companies directed significant financial resources
toward lobbying Congress in an effort to exclude this policy from the
ACA. 126 As a result, lawmakers are instead focusing on incrementally
addressing the public’s concerns through less impactful policies,
including pressuring companies to set lower prices. 127
The current administration has proposed the most comprehensive
effort yet to address prescription costs with a plan entitled “American
123. See Rena M. Conti & Meredith B. Rosenthal, Pharmaceutical Policy
Reform – Balancing Affordability With Incentives for Innovation, 374 NEW ENGLAND
J. MED. 703, 704 (2016).
124. Id.
125. Id.
126. Id. (citing Daemmrich, supra note 14).
127. Id. at 704–05.
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Patients First.” 128 Under this plan, the Department of Health and
Human Services (HHS) has identified challenges in the American drug
market and isolated goals for reform including improving competition
and enabling cost negotiation. 129
Under this plan, by lifting previously imposed barriers and shifting
coverage of medications between sectors, Medicare will be able to
negotiate the cost of physician-administered medications. 130 These
subtle changes may achieve the outcome American’s are hoping for,
but only if Congress is willing to revisit the laws that are responsible
for driving up prescription drug costs in the first place. 131 While this
proposition is a step in the right direction, it fails to address any solution
to make medications more affordable by focusing primarily on
increasing competition. 132 While the plan discusses the influence of
increased competition on the prices of the medications, 133 it fails to
address how the plan will actually attack the price of the medication
itself. Experts believe failing to focus on decreasing the net price of
prescription medications undermines the potential positive effects of
the proposed legislation.
Though policy makers seem to be interested in addressing the
significant weaknesses in our current healthcare system, as of yet few
128. DEP’T OF HEALTH & HUMAN SERVICES, AMERICAN PATIENTS FIRST: THE
TRUMP ADMINISTRATION BLUEPRINT TO LOWER DRUG PRICES AND REDUCE OUT-OFPOCKET COSTS 9 (2018).
129. “HHS has identified four challenges in the American drug market: high list
prices for drugs; seniors and government programs overpaying for drugs due to lack
of the latest negotiation tools; high and rising out-of-pocket costs for consumers; [and]
foreign governments free-riding off of American investment in innovation.” Id.
130. On August 7, 2018, U.S. Health and Human Services Secretary Alex Azar
announced President Trump’s plan to reduce high prescription drug prices by
establishing a number of solutions to enhance competition among retail and hospital
administered drugs in an effort to bring drug prices down. Avik Roy, Trump’s New
Medicare Rule to Reduce Prescription Drug Prices Through Competition, FORBES:
THE APOTHECARY (Aug. 7, 2018 9:44 PM), https://www.forbes.com/sites/the
apothecary/2018/08/07/trumps-new-medicare-rule-to-reduce-prescription-drug-price
s-through-competition/#29d4746f7e88.
131. These include the Orphan Drug Act of 1983 which allows companies with
no intellectual property to charge high prices for drugs used to treat rare diseases, and
the Biologics Price, Competition, and Innovation Act of 2009 which has not done
enough to encourage competition for off-patent biotech drugs.
132. See Roy, supra note 130.
133. Id.
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truly effective solutions have been put in place. Moreover, the
traditional healthcare industry has not taken steps to adapt to the
imminent changes in the marketplace and prevent these historical
shortfalls from being inevitably exacerbated. Policy makers should
take an honest, comprehensive look back at the things that have not
been working in the healthcare industry and change course now before
it is too late.
B. Proactive Reform
Alternatively – and perhaps more realistically – we should look to
trends in other industries as a model for legislative reform in an effort
to protect and propel the healthcare industry as it braces for change.
Despite the value in reflecting on past successes or failures, perhaps it
would also be valuable to consider the hurdles the industry will face as
the industry embraces direct-to-consumer health methods.
As discussed above, if history repeats itself, big tech companies
will change the way we receive healthcare. Many other industries have
been disrupted by direct-to-consumer strategies in this way, and
healthcare is likely next. 134 Thus, for the traditional healthcare delivery
model to survive, the industry should adopt strategies that have proved
effective in other sectors. In essence, the patient should be viewed as a
consumer and the service should be redefined as a product.
1. The FTC and HIPAA
Traditionally, legislatures are less restrictive in terms of oversight
over the sale of goods versus the implementation of services. This
distinction is illustrated in the healthcare industry by Congress’s
willingness to embrace the sale of drugs online, and simultaneous
refusal to reimburse medical visits performed online; Congress allowed
for online pharmacies nearly a decade before addressing
telemedicine. 135 While HIPAA currently protects patient information
in a traditional setting, it has not been adjusted to protect patient

134. Tech Bets, supra note 49.
135. Compare 21 U.S.C. § 831 (2009), with 38 U.S.C. § 1730C (2018).
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information in a non-traditional, direct-to-consumer context. 136 To
reconcile this contradiction, healthcare oversight should be adjusted,
namely how FTC in HIPAA regulations operate, to allow the traditional
healthcare industry to incorporate alternative delivery options.
2. mHealth Regulation
Though the capabilities of mHealth apps continue to evolve,
government regulation has not kept up. Consequently, users are left
exposed to privacy risks and being misled by overpromising,
unregulated applications. 137 To bring mHealth under the ambit of
current consumer protections, healthcare reform should allow hospitals
to implement direct-to-consumer options like mHealth.
Experts predict hospitals could save over $300 billion in
administrative costs a year by implementing mHealth apps on a large
scale by “reducing travel time and improving communication of
medical decisions.” 138 The use of mHealth apps will also “reduce
emergency room visits and hospital readmissions [by providing] timely,
efficient, and effective care management” as an alternative to relying
solely on the traditional treatment scheme. 139 Capitalizing on this
delivery system could help keep healthcare dollars contained within the
traditional delivery model.
As mHealth and other emerging technologies are already
revolutionizing the healthcare industry, the strategies put in place now
to cope with these inevitable changes are critically important. The gaps
and overlaps in regulatory measures that place a yoke on traditional
healthcare institutions’ abilities to modernize by utilizing these
technologies are thus ripe for reconsideration.

136. “The dichotomy between the highly regulated HIPAA zone and the lightly
regulated external zone is a function of the sectoral approach to data protection in the
United States.” Terry, supra note 21, at 339.
137. Ovansian, supra note 88, at 174.
138. Flaherty, supra note 76, at 420.
139. Barry Liss, HIPAA and Mobile Health: Where’s the App for That, 34
COMPUTER & INTERNET LAW. 9, 9 (2017).
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3. Monopoly Oversight
Finally, the legislature should take a hard look at the potential
monopolization of healthcare by big tech companies that are already
consolidating emerging, unregulated markets, and which will likely
develop their own healthcare systems. Companies like Amazon and
Google are shifting their focus to health in an effort to resolve all the
problems the American consumer faces when it comes to care. 140
In 2018, Google launched a health initiative to monetize “its
profitable search and business proficiencies within the world of
healthcare[.]” 141 Moreover, Google’s newest member of its executive
team Dr. David Feinberg is an advocate for bringing care out of the
medical facility and into the home. 142 Previously referring to hospitals
as “Blockbuster,” Dr. Feinberg predicts 50% of today’s inpatient
medical services “will soon be rendered in people’s homes, and without
the many risks associated with a hospital stay.” 143 The traditional
healthcare model is no match for the energy and resources of big tech.
Without embracing this shift in care, the American consumer will
watch these tech companies swallow up the largest hospital systems in
the country. 144 Thus, for the traditional healthcare delivery model to
survive the current and future disruptions within the industry, and avoid
companies like Amazon and Google overtaking them, serious
regulatory reform is needed.
CONCLUSION
While Congress continues its partisan battles over healthcare
reform, it is failing to see the forest through the trees and missing the
clear shift within the industry. Tragically, those in need of healthcare
are the ones that will continue to suffer. As nearly all products and
services available to the American consumer today have, the healthcare
industry will likely shift substantially into different delivery models.
Millennials’ expectation of direct-to-consumer purchasing, in

140.
141.
142.
143.
144.

Tech Bets, supra note 49.
Pearl, supra note 1.
Id.
Id.
C.f. Taylor, Hanbury, & Green, supra note 51.
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combination with the $3.5 trillion incentive, 145 makes this shift
practically inevitable. Over the next decade, the patient will become
the consumer, and today the patient-consumer has no place in
traditional healthcare delivery.
The writing is on the wall, our healthcare system is fundamentally
unprepared for the change that is coming. The patchwork of
inconsistent regulation and selectivity of legislative priorities have left
the American consumer of healthcare out in the cold. The maneuvering
of big tech companies, the proliferation of online pharmacies, and the
emergence of opportunistically unregulated medical devices all point to
one thing – action is needed now. As with many of the partial solutions
currently in place, the critical issues our healthcare system will face in
the coming years will only pass on more costs to consumers if
something is not done to resolve them.
Legislators need to reconcile the gaps in regulation that are
currently being exploited and plan ahead for market shifts that will
inevitably affect the rights and pocketbooks of patients. Decision
makers within the healthcare industry should take both internal action
to deal realistically with costs, taking into account their need to
modernize, and lobby for external actions to modulate the imminent
disruption of their industry. The purpose of having a healthcare system
in the first place is to ensure that patients can get the care they need. Of
course, this need must be balanced with economic interests of
institutions engaged in the business of providing care. However,
without thoughtful and comprehensive action to head off the dynamics
emerging in our current system, the American consumer of healthcare
will continue to bare ever increasing costs. Change is coming—and
change is needed.
Mollie Levy*
145. See Pearl, supra note 1.
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